BioLife Sciences Inc. (OTCPK:BLFE) Announces the Launch of Their New Copper Infused Face Masks
Toronto, Ontario, Canada, Feb. 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioLife Sciences (OTCPK:…
Staff
Innovation Pharma Provides Study Details for Ongoing Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
WAKEFIELD, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical…
No B.S. Skincare, A PureK Holdings Subsidiary, Announces Transition to All-New Sustainable Aluminum Packaging
Award-Winning Indie Brand Announces Step Forward in Sustainable Packaging MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE)…
Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 with Planned Completion and Emergency Use Authorization Request
TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
Albireo Spotlights Global Patient Communities on Rare Disease Day
– Calls to unite global communities affected by rare diseases – – Albireo supports increasing…
Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) —…
Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan
Agreement includes COVID-19 vaccine technology transfer to Takeda for local manufacturing and commercialization in Japan…
HMS Reports Fourth Quarter and Full Year 2020 Financial Results
FY’20 Total Revenue of $673.3 Million, +7.5% vs. FY’19 FY’20 Net Income of $70.1 Million,…
Pharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study Evaluating PHVS416 for the On-Demand Treatment of HAE
ZUG, Switzerland, Feb. 26, 2021 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused…